Literature DB >> 25992974

Synthesis and Biological Evaluation of Novel Olean-28,13β-lactams as Potential Antiprostate Cancer Agents.

Yong Ai1,2, Yang Hu1, Fenghua Kang1,2, Yisheng Lai1,2, Yanju Jia1, Zhangjian Huang1,2, Sixun Peng1,2, Hui Ji1, Jide Tian3, Yihua Zhang1,2.   

Abstract

γ-Lactam is an important structural motif in a large number of biologically active natural products and synthetic small pharmaceutical molecules. However, there is currently no effective approach to construct γ-lactam ring directly from natural rigid polycyclic amides. Herein, we report a facile methodology for synthesis of a new group of n class="Chemical">olean-28,13β-lactams (10a-j) from their corresponding amides, promoted by an easily available reagent 2,3-dichloro-5,6-dicyanobenzoquinone (DDQ), through an intramolecular dehydrogenative C-N coupling reaction via a radical ion mechanism. Biological evaluation indicated that the most active lactam 10h displayed potent antiproliferative activity against human cancer cells but 13.84- to 16.92-fold less inhibitory activity on noncancer cells in vitro. In addition, 10h significantly inhibited the growth of implanted prostate cancer in vivo. Furthermore, 10h induced cell cycle arrest and apoptosis and down-regulated the AKT/mTOR signaling in DU-145 cells. Finally, 10h was more stable in rat plasma and human liver microsomes than CDDO-Me and had little hERG channel inhibitory activity. Collectively, 10h may be a potential antiprostate cancer agent for further investigation.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25992974     DOI: 10.1021/jm5020023

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  7 in total

1.  Novel hybrids derived from aspirin and chalcones potently suppress colorectal cancer in vitro and in vivo.

Authors:  Shan Lu; Obinna N Obianom; Yong Ai
Journal:  Medchemcomm       Date:  2018-08-27       Impact factor: 3.597

2.  Synthesis and biological evaluation of 3-nitro-4-chromanone derivatives as potential antiproliferative agents for castration-resistant prostate cancer.

Authors:  Huiqing Chen; Yajing Xing; Jia Xie; Jiuqing Xie; Dong Xing; Jie Tang; Fan Yang; Zhengfang Yi; Wen-Wei Qiu
Journal:  RSC Adv       Date:  2019-10-21       Impact factor: 4.036

3.  Antihepatocarcinoma Effect of Portulaca oleracea L. in Mice by PI3K/Akt/mTOR and Nrf2/HO-1/NF-κB Pathway.

Authors:  Zheng Guoyin; Peng Hao; Li Min; Gu Wei; Chen Zhe; Ling Changquan
Journal:  Evid Based Complement Alternat Med       Date:  2017-06-04       Impact factor: 2.629

4.  Antitumorigenic and antiangiogenic efficacy of apatinib in liver cancer evaluated by multimodality molecular imaging.

Authors:  Qian Liang; Lingxin Kong; Yang Du; Xu Zhu; Jie Tian
Journal:  Exp Mol Med       Date:  2019-07-08       Impact factor: 8.718

5.  A synthesized olean-28,13β-lactam targets YTHDF1-GLS1 axis to induce ROS-dependent metabolic crisis and cell death in pancreatic adenocarcinoma.

Authors:  Shijia Wu; Yong Ai; Huimin Huang; Guangyu Wu; Shipeng Zhou; Weilong Hong; Percy David Papa Akuetteh; Guihua Jin; Xingling Zhao; Yihua Zhang; Xiaolong Zhang; Linhua Lan
Journal:  Cancer Cell Int       Date:  2022-04-02       Impact factor: 5.722

6.  Metal-free oxidative cross-dehydrogenative coupling of quinones with benzylic C(sp3)-H bonds.

Authors:  Yu Dong; Jian Yang; Shuai He; Zhi-Chuan Shi; Yu Wang; Xiao-Mei Zhang; Ji-Yu Wang
Journal:  RSC Adv       Date:  2019-09-02       Impact factor: 4.036

Review 7.  The Sources of Essential Fatty Acids for Allergic and Cancer Patients; a Connection with Insight into Mammalian Target of Rapamycin: A Narrative Review

Authors:  Zhila Arshad; Soheila Rezapour-Firouzi; Mahshid Mohammadian
Journal:  Asian Pac J Cancer Prev       Date:  2018-09-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.